Published in J Gen Virol on May 01, 2000
The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A (2005) 7.39
Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev (2007) 6.38
The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med (2006) 5.94
H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J Virol (2000) 5.17
Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog (2007) 4.49
Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci U S A (2009) 3.89
Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. J Virol (2001) 3.43
Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog (2008) 3.37
Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis (2006) 3.27
An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe (2008) 2.81
Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc Natl Acad Sci U S A (2008) 2.72
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol (2008) 2.71
Host determinant residue lysine 627 lies on the surface of a discrete, folded domain of influenza virus polymerase PB2 subunit. PLoS Pathog (2008) 2.60
PB2 residue 271 plays a key role in enhanced polymerase activity of influenza A viruses in mammalian host cells. J Virol (2010) 2.35
In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J Virol (2010) 2.23
Molecular changes in the polymerase genes (PA and PB1) associated with high pathogenicity of H5N1 influenza virus in mallard ducks. J Virol (2007) 2.20
Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms. J Biol Chem (2010) 1.89
Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains. PLoS One (2010) 1.87
H5N1 influenza viruses: outbreaks and biological properties. Cell Res (2009) 1.72
The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model. J Virol (2009) 1.68
Evidence of expanded host range and mammalian-associated genetic changes in a duck H9N2 influenza virus following adaptation in quail and chickens. PLoS One (2008) 1.63
Identification of human-to-human transmissibility factors in PB2 proteins of influenza A by large-scale mutual information analysis. BMC Bioinformatics (2008) 1.61
Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets. Proc Natl Acad Sci U S A (2008) 1.53
Interaction of the influenza a virus nucleocapsid protein with the viral RNA polymerase potentiates unprimed viral RNA replication. J Virol (2008) 1.47
Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. Antiviral Res (2008) 1.47
Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells. J Virol (2005) 1.47
Synthetic viruses: a new opportunity to understand and prevent viral disease. Nat Biotechnol (2009) 1.47
Sequences in influenza A virus PB2 protein that determine productive infection for an avian influenza virus in mouse and human cell lines. J Virol (2001) 1.42
Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier. J Virol (2013) 1.40
NP, PB1, and PB2 viral genes contribute to altered replication of H5N1 avian influenza viruses in chickens. J Virol (2008) 1.34
Viral reassortment and transmission after co-infection of pigs with classical H1N1 and triple-reassortant H3N2 swine influenza viruses. J Gen Virol (2010) 1.23
Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread. J Virol (2013) 1.23
Full factorial analysis of mammalian and avian influenza polymerase subunits suggests a role of an efficient polymerase for virus adaptation. PLoS One (2009) 1.22
PA residues in the 2009 H1N1 pandemic influenza virus enhance avian influenza virus polymerase activity in mammalian cells. J Virol (2011) 1.22
Comparative analysis of avian influenza virus diversity in poultry and humans during a highly pathogenic avian influenza A (H7N7) virus outbreak. J Virol (2011) 1.21
A 27-amino-acid deletion in the neuraminidase stalk supports replication of an avian H2N2 influenza A virus in the respiratory tract of chickens. J Virol (2010) 1.18
Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice. J Virol (2009) 1.18
Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam. J Gen Virol (2010) 1.17
Unstable polymerase-nucleoprotein interaction is not responsible for avian influenza virus polymerase restriction in human cells. J Virol (2012) 1.14
Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 influenza virus and circulating influenza A viruses. J Virol (2011) 1.13
Interaction of the influenza A virus polymerase PB2 C-terminal region with importin alpha isoforms provides insights into host adaptation and polymerase assembly. J Biol Chem (2011) 1.11
Influenza virus adaptation PB2-627K modulates nucleocapsid inhibition by the pathogen sensor RIG-I. Cell Host Microbe (2015) 1.05
The human H5N1 influenza A virus polymerase complex is active in vitro over a broad range of temperatures, in contrast to the WSN complex, and this property can be attributed to the PB2 subunit. J Gen Virol (2008) 1.05
Reversion of PB2-627E to -627K during replication of an H5N1 Clade 2.2 virus in mammalian hosts depends on the origin of the nucleoprotein. J Virol (2011) 1.03
Influence of PB2 host-range determinants on the intranuclear mobility of the influenza A virus polymerase. J Gen Virol (2011) 1.03
The role of viral, host, and secondary bacterial factors in influenza pathogenesis. Am J Pathol (2015) 1.02
Ostrich involvement in the selection of H5N1 influenza virus possessing mammalian-type amino acids in the PB2 protein. J Virol (2009) 1.01
Mutations in polymerase genes enhanced the virulence of 2009 pandemic H1N1 influenza virus in mice. PLoS One (2012) 1.00
Biochemical impact of the host adaptation-associated PB2 E627K mutation on the temperature-dependent RNA synthesis kinetics of influenza A virus polymerase complex. J Biol Chem (2011) 0.99
Influenza polymerase activity correlates with the strength of interaction between nucleoprotein and PB2 through the host-specific residue K/E627. PLoS One (2012) 0.98
The role of RNA folding free energy in the evolution of the polymerase genes of the influenza A virus. Genome Biol (2009) 0.93
The PA-gene-mediated lethal dissemination and excessive innate immune response contribute to the high virulence of H5N1 avian influenza virus in mice. J Virol (2012) 0.91
Different incubation temperatures affect viral polymerase activity and yields of low-pathogenic avian influenza viruses in embryonated chicken eggs. Arch Virol (2011) 0.90
Naturally occurring mutations in the PA gene are key contributors to increased virulence of pandemic H1N1/09 influenza virus in mice. J Virol (2014) 0.89
Analysis by single-gene reassortment demonstrates that the 1918 influenza virus is functionally compatible with a low-pathogenicity avian influenza virus in mice. J Virol (2012) 0.89
Investigation of influenza virus polymerase activity in pig cells. J Virol (2012) 0.88
Functional analysis of conserved motifs in influenza virus PB1 protein. PLoS One (2012) 0.86
Conserved features of the PB2 627 domain impact influenza virus polymerase function and replication. J Virol (2014) 0.84
Mammalian adaptation in the PB2 gene of avian H5N1 influenza virus. J Virol (2013) 0.83
Viral and host factors required for avian H5N1 influenza A virus replication in mammalian cells. Viruses (2013) 0.82
The RNA polymerase PB2 subunit of influenza A/HongKong/156/1997 (H5N1) restricts the replication of reassortant ribonucleoprotein complexes [corrected]. PLoS One (2012) 0.81
Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review. Ecohealth (2015) 0.80
Influenza A viruses with different amino acid residues at PB2-627 display distinct replication properties in vitro and in vivo: revealing the sequence plasticity of PB2-627 position. Virology (2014) 0.80
Genomic Signatures for Avian H7N9 Viruses Adapting to Humans. PLoS One (2016) 0.79
Quantifying the fitness advantage of polymerase substitutions in Influenza A/H7N9 viruses during adaptation to humans. PLoS One (2013) 0.79
The avian-origin PB1 gene segment facilitated replication and transmissibility of the H3N2/1968 pandemic influenza virus. J Virol (2015) 0.78
Emergence of avian influenza viruses with enhanced transcription activity by a single amino acid substitution in the nucleoprotein during replication in chicken brains. J Virol (2011) 0.78
Feature selection methods for identifying genetic determinants of host species in RNA viruses. PLoS Comput Biol (2013) 0.77
Additional Evidence That the Polymerase Subunits Contribute to the Viral Replication and the Virulence of H5N1 Avian Influenza Virus Isolates in Mice. PLoS One (2015) 0.75
Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs. PLoS One (2015) 0.75
The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment. MBio (2016) 0.75
Recombinant influenza virus with a pandemic H2N2 polymerase complex has a higher adaptive potential than one with seasonal H2N2 polymerase complex. J Gen Virol (2015) 0.75
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 8.59
Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components. Clin Orthop Relat Res (1990) 5.50
Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. J Virol (2001) 3.43
Macular hole formation: new data provided by optical coherence tomography. Arch Ophthalmol (1999) 2.87
Implementation of the Ottawa ankle rules in France. A multicenter randomized controlled trial. JAMA (1997) 2.34
Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence. EMBO J (1989) 2.24
A coding RNA sequence acts as a replication signal in cardioviruses. Proc Natl Acad Sci U S A (1999) 2.22
Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in Macular Hole Surgery Group. Ophthalmology (1999) 2.16
Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology (2001) 2.11
Foveal pseudocyst as the first step in macular hole formation: a prospective study by optical coherence tomography. Ophthalmology (2001) 2.00
Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia. Eye (Lond) (2008) 1.96
Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1. Proc Natl Acad Sci U S A (1983) 1.94
Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir. Antimicrob Agents Chemother (2006) 1.85
Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med (2001) 1.75
Clinical and brain MRI follow-up study of a family with COL4A1 mutation. Neurology (2007) 1.71
Severity of diabetic microvascular complications is associated with a low soluble RAGE level. Diabetes Metab (2008) 1.68
A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1. EMBO J (1983) 1.59
Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres. Diabetes Metab (2009) 1.56
Molecular cloning of the genome of poliovirus type 1. Proc Natl Acad Sci U S A (1981) 1.56
First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill (2013) 1.55
Femoral offset: anatomical concept, definition, assessment, implications for preoperative templating and hip arthroplasty. Orthop Traumatol Surg Res (2009) 1.54
Is alumina-on-alumina ceramic bearings total hip replacement the right choice in patients younger than 50 years of age? A 7- to 15-year follow-up study. Orthop Traumatol Surg Res (2010) 1.54
Dissociated optic nerve fiber layer appearance of the fundus after idiopathic epiretinal membrane removal. Ophthalmology (2001) 1.51
Hereditary infantile hemiparesis, retinal arteriolar tortuosity, and leukoencephalopathy. Neurology (2003) 1.50
Glycaemic control and development of retinopathy in type 2 diabetes mellitus: a longitudinal study. Diabet Med (1998) 1.49
Protein F. A novel F(ab)-binding factor, present in normal liver, and largely released in the digestive tract during hepatitis. J Immunol (1990) 1.47
Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles. J Virol (1990) 1.41
Reverse shoulder arthroplasty for the treatment of three- and four-part fractures of the proximal humerus in the elderly: a prospective review of 43 cases with a short-term follow-up. J Bone Joint Surg Br (2007) 1.40
[Total hip prosthesis with screw rings. Results over 2 years of a series of 198 consecutive prostheses]. Rev Chir Orthop Reparatrice Appar Mot (1991) 1.39
Sclerochoroidal calcification associated with Gitelman syndrome. Am J Ophthalmol (1999) 1.38
Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J Virol (1997) 1.36
Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy. Diabetologia (2006) 1.33
A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles. Science (1986) 1.30
Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. J Virol (1991) 1.28
Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1). Euro Surveill (2014) 1.27
Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J Clin Virol (2014) 1.24
The transcription/replication activity of the polymerase of influenza A viruses is not correlated with the level of proteolysis induced by the PA subunit. Virology (2001) 1.24
OPHDIAT: quality-assurance programme plan and performance of the network. Diabetes Metab (2008) 1.17
Two-stage reconstruction of post-traumatic segmental tibia bone loss with nailing. Orthop Traumatol Surg Res (2010) 1.16
vig-1, a new fish gene induced by the rhabdovirus glycoprotein, has a virus-induced homologue in humans and shares conserved motifs with the MoaA family. J Virol (1999) 1.15
Processing of the E1 glycoprotein of hepatitis C virus expressed in mammalian cells. J Gen Virol (1996) 1.14
Comparison of optical coherence tomography models OCT1 and Stratus OCT for macular retinal thickness measurement. Br J Ophthalmol (2005) 1.14
Fatigue in disease-free cancer patients compared with fatigue in patients with chronic fatigue syndrome. Support Care Cancer (2001) 1.14
Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1. J Virol (1992) 1.11
Relationship between macular hole size and the potential benefit of internal limiting membrane peeling. Br J Ophthalmol (2006) 1.10
Traumatic lumbosacral dislocation: four cases and review of literature. Clin Orthop Relat Res (2004) 1.10
Long-term incidence of reopening of macular holes. Ophthalmology (2000) 1.10
Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol (1995) 1.09
Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts. Virology (1995) 1.09
Attenuated Mengo virus: a new vector for live recombinant vaccines. J Virol (1995) 1.09
Acute transient myopia induced by indapamide. Am J Ophthalmol (2000) 1.09
Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120. Proc Natl Acad Sci U S A (1994) 1.07
Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein. J Gen Virol (2001) 1.07
Binding of the hemagglutinin from human or equine influenza H3 viruses to the receptor is altered by substitutions at residue 193. Arch Virol (2004) 1.05
Retinal abnormalities in CADASIL: a retrospective study of 18 patients. J Neurol Neurosurg Psychiatry (2004) 1.04
Time course and risk factors of post-stroke fatigue: a prospective cohort study. Eur J Neurol (2010) 1.04
New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel. Eye (Lond) (2012) 1.04
A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks its myristoylation and prevents viral assembly. J Gen Virol (1991) 1.03
The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J Virol (2008) 1.03
Late reopening of successfully treated macular holes. Br J Ophthalmol (1997) 1.00
Recombination and rescue between temperature-sensitive mutants of poliovirus type 1. Virology (1984) 0.99
Early prediction of favourable recovery 6 months after mild traumatic brain injury. J Neurol Neurosurg Psychiatry (2007) 0.99
N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients. Diabetes Metab (2003) 0.98
[Central serous chorioretinopathy and systemic steroid therapy]. J Fr Ophtalmol (2001) 0.97
Decreased fractal correlation in diurnal physical activity in chronic fatigue syndrome. Methods Inf Med (2004) 0.97
Production of influenza virus in serum-free mammalian cell cultures. Dev Biol Stand (1999) 0.97
The relation between daytime sleepiness, fatigue, and reduced motivation in patients with adult onset myotonic dystrophy. J Neurol Neurosurg Psychiatry (2003) 0.96
Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol (2006) 0.95
Cementless total hip arthroplasty using the anatomic medullary locking stem. Results using a survivorship analysis. Clin Orthop Relat Res (1989) 0.95
Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants. Br J Ophthalmol (2005) 0.95
Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus. Vaccine (1996) 0.95
Treatment of complex fractures of the distal radius: a prospective randomised comparison of external fixation 'versus' locked volar plating. Injury (2011) 0.95
[Surgical treatment of post-traumatic macular holes]. J Fr Ophtalmol (1997) 0.93
Visual field loss after vitrectomy for full-thickness macular holes. Am J Ophthalmol (1997) 0.93
Immunogenicity of foreign peptide epitopes expressed in bacterial envelope proteins. Res Microbiol (1991) 0.93
Macular traction detachment and diabetic edema associated with posterior hyaloidal traction. Am J Ophthalmol (2001) 0.92
Involvement of both DNA polymerases alpha and gamma in the replication of adenovirus deoxyribonucleic acid in vitro. Virology (1980) 0.92
S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses. Euro Surveill (2011) 0.92
[Measurement of head penetration on digitalized radiographs: reproducibility and accuracy]. Rev Chir Orthop Reparatrice Appar Mot (2005) 0.91
The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab (2009) 0.91
Binding of nuclear factors to functional domains of the duck hepatitis B virus enhancer. J Virol (1993) 0.90
Growth factors and diabetic retinopathy. Diabetes Metab (1997) 0.90
Evaluation of fluorescein-labeled autologous leukocytes for examination of retinal circulation in humans. Curr Eye Res (2000) 0.90
Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD). Diabetes Metab (2004) 0.90
Evaluation of the effect of JPEG and JPEG2000 image compression on the detection of diabetic retinopathy. Eye (Lond) (2006) 0.89
Epidemiology of diabetic retinopathy: expected vs reported prevalence of cases in the French population. Diabetes Metab (2009) 0.89
Nuclear localization of poliovirus capsid polypeptide VP1 expressed as a fusion protein with SV40-VP1. Gene (1985) 0.88
Endoscopically assisted reconstruction of acute acromioclavicular joint dislocation using a synthetic ligament. Outcomes at 12 months. Orthop Traumatol Surg Res (2011) 0.87
Total knee replacement following intra-articular malunion. Orthop Traumatol Surg Res (2011) 0.87
Development of intelligence and memory in children with hemiplegic cerebral palsy. The deleterious consequences of early seizures. Brain (1992) 0.87
SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement. Hong Kong Med J (2012) 0.87
Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft. Am J Transplant (2006) 0.86
Total knee replacement in the fixed valgus deformity using a lateral approach: role of the automatic iliotibial band release for a successful balancing. Int Orthop (2008) 0.86